| Biological Information | |
|---|---|
| Background Information: | N-terminal GST-tagged, recombinant, full length, human PKD3. PKD3 is a member of the serine/threonine protein kinase family. Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. |
| Target Class: | Kinase |
| Family: | CAMK (Calcium/calmodulin-dep. kinase) |
| Sub Family: | Serine/threonine kinase |
| Accession Number: | NM_005813.3 |
| Target Name: | PKD3 |
| Target Aliases: | PKD3, KPCD3, PRKD3, PKC-nu, EPK2, PRKCN ,nPKC-NU, PKCnu, Serine/threonine-protein kinase D3 protein kinase C nu type protein kinase EPK2 nPKC-nu, O94806 |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 12 months at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Assay Information | |
| Assay Type: | Biochemical |
| Clinical Relevance | |
| Therapeutic Area: | Oncology/Immuno-Oncology |
PKD3, active
10 µg of active PKD3. N-Terminal GST-tagged, recombinant, full length, human PKD3.
Datasheets
15-013_Datasheet
View Document